Triple Point Venture Growth Bdc Corp. TPVG
We take great care to ensure that the data presented and summarized in this overview for TriplePoint Venture Growth BDC Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding TPVG
View all-
Invesco Ltd. Atlanta, GA1.12MShares$8.78 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny780KShares$6.12 Million0.01% of portfolio
-
Two Sigma Investments, LP New York, NY556KShares$4.36 Million0.01% of portfolio
-
Marshall Wace, LLP London, X0324KShares$2.54 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN280KShares$2.2 Million0.0% of portfolio
-
Legal & General Group PLC London, X0261KShares$2.05 Million0.0% of portfolio
-
Virtus ETF Advisers LLC New York, NY198KShares$1.56 Million0.68% of portfolio
-
Trexquant Investment LP Stamford, CT168KShares$1.32 Million0.02% of portfolio
-
Golden Green, Inc.144KShares$1.13 Million1.58% of portfolio
-
Morgan Stanley New York, NY127KShares$996,9970.0% of portfolio
Latest Institutional Activity in TPVG
Top Purchases
Top Sells
About TPVG
TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.
Insider Transactions at TPVG
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 13
2024
|
Sajal Srivastava President |
BUY
Open market or private purchase
|
Direct |
24,083
+4.08%
|
$168,581
$7.09 P/Share
|
Aug 12
2024
|
Sajal Srivastava President |
BUY
Open market or private purchase
|
Direct |
11,298
+4.31%
|
$79,086
$7.02 P/Share
|
Mar 14
2024
|
Katherine J Park Director |
BUY
Open market or private purchase
|
Direct |
2,500
+33.33%
|
$22,500
$9.35 P/Share
|
Mar 12
2024
|
Stephen Cassani Director |
BUY
Open market or private purchase
|
Direct |
500
+7.46%
|
$4,500
$9.9 P/Share
|
Mar 11
2024
|
Stephen Cassani Director |
BUY
Open market or private purchase
|
Direct |
1,103
+16.21%
|
$9,927
$9.99 P/Share
|
Dec 18
2023
|
Cynthia M. Fornelli Director |
BUY
Open market or private purchase
|
Direct |
1,000
+10.18%
|
$10,000
$10.47 P/Share
|
Nov 09
2023
|
Katherine J Park Director |
BUY
Open market or private purchase
|
Direct |
2,480
+49.8%
|
$24,800
$10.17 P/Share
|
Nov 08
2023
|
Katherine J Park Director |
BUY
Open market or private purchase
|
Direct |
20
+50.0%
|
$200
$10.15 P/Share
|
Dec 19
2022
|
Kimberley H Vogel Director |
BUY
Open market or private purchase
|
Direct |
2,764
+50.0%
|
$27,640
$10.84 P/Share
|
Dec 19
2022
|
Cynthia M. Fornelli Director |
BUY
Open market or private purchase
|
Direct |
1,000
+12.93%
|
$11,000
$11.15 P/Share
|
Sep 09
2022
|
Christopher M. Mathieu Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+21.98%
|
$130,000
$13.34 P/Share
|
Sep 09
2022
|
Cynthia M. Fornelli Director |
BUY
Open market or private purchase
|
Direct |
1,000
+15.29%
|
$13,000
$13.35 P/Share
|
Jun 17
2022
|
Christopher M. Mathieu Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+28.17%
|
$120,000
$12.16 P/Share
|
Jun 09
2022
|
Cynthia M. Fornelli Director |
BUY
Open market or private purchase
|
Direct |
1,000
+18.49%
|
$14,000
$14.75 P/Share
|
Dec 14
2021
|
Cynthia M. Fornelli Director |
BUY
Open market or private purchase
|
Direct |
500
+13.25%
|
$8,500
$17.05 P/Share
|
Aug 09
2021
|
Cynthia M. Fornelli Director |
BUY
Open market or private purchase
|
Direct |
500
+15.58%
|
$7,500
$15.7 P/Share
|
Mar 09
2021
|
Cynthia M. Fornelli Director |
BUY
Open market or private purchase
|
Direct |
1,000
+32.26%
|
$14,000
$14.83 P/Share
|
Last 12 Months Summary
Open market or private purchase | 40.5K shares |
---|